CN Patent

CN105943534A — 用于局部治疗免疫相关疾病的局部lfa-1拮抗剂

Assigned to Novartis AG · Expires 2016-09-21 · 10y expired

What this patent protects

本发明提供适于局部给药的特定配制的LFA‑1拮抗剂或其药用可接受的盐。具体地，所述LFA‑1拮抗剂由于具有快速全身清除率而特别适用于局部治疗。本发明还包括使用本发明LFA‑1局部制剂治疗和预防免疫相关疾病的方法。

USPTO Abstract

本发明提供适于局部给药的特定配制的LFA‑1拮抗剂或其药用可接受的盐。具体地，所述LFA‑1拮抗剂由于具有快速全身清除率而特别适用于局部治疗。本发明还包括使用本发明LFA‑1局部制剂治疗和预防免疫相关疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105943534A
Jurisdiction
CN
Classification
—
Expires
2016-09-21
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.